Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YJ001 Spray for Diabetic Peripheral Neuropathic Pain
NCT07859111Phase 3Recruiting
- Sponsor
- Zhejiang Hanmai Pharmaceutical Technology Co., Ltd.
- Start
- Aug 2026
- Primary completion
- Aug 2028
- Countries
- 1
01
Overview
A Phase 3 trial of YJ001 in diabetic polyneuropathy (DPN), sponsored by Zhejiang Hanmai Pharmaceutical Technology Co., Ltd.. Started Aug 2026; status: recruiting.
02
Drugs
YJ001
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on NCT07859111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07859111.